Rate My Professor Gertrude Yap

Christina Gertrude Yap is an Associate Professor in Biomedical Sciences at the Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, a position she has held since 2011. She commenced her academic career with a Diploma in Medical Laboratory Technology, majoring in Pharmacology and Physiology, from Universiti Sains Malaysia in 1990. She then obtained a Bachelor of Biomedical Sciences (Honors) in 2001 and a Masters in Medical Sciences in 2005 from the University of Malaya. Yap earned her PhD in Biomedical Sciences from Monash University in 2012, with her thesis titled "Candidate Early Predictors for Diabetic Nephropathy," and a Graduate Certificate in Higher Education in 2015 from the same university. Her professional experience includes roles as Medical Technologist at Subang Jaya Medical Center from 1990 to 1993 and at the University of Malaya's Department of Physiology from 1993 to 2005, Lecturer at the International Medical University from 2005 to 2007, Assistant Lecturer at Monash University Malaysia from 2010 to 2012, and Senior Lecturer from 2012 to 2018. In her current role, she coordinates Physiology and Hematology in the MBBS course, MED1100 Year 1 Problem-Based Learning and Case Commentary Assignment in the MD course, and serves as a member of the Student Support Committee.

Yap's research focuses on pharmacokinetics and xenobiotic interactions with drug metabolizing enzymes such as CYP2E1, development of early biomarkers for diabetic nephropathy, translational studies of diabetic nephropathy, teaching and learning methods in medical education, and early biomolecules associated with metabolic syndromes, obesity, and pre-diabetes. Her technical expertise encompasses HPLC, LC-MS/MS, genomics using Genespring and Partek software, proteomics, metabolomics, bioinformatics, animal experimental models, and cell culture. Notable publications include "Strategies for optimization of hypoglycemia rat models" (2025), "In Silico exploration of Karanjin for anti-obesity potential through ADMET profiling, network pharmacology, molecular docking, and molecular dynamics simulations" (2025), "Influence of Clinical Risk Factors on International Normalized Ratio Control in Patients on Warfarin Therapy: A Systematic Review" (2025), "Environmental enrichment and the combined interventions of EE and metformin enhance hippocampal neuron survival and hippocampal-dependent memory in type 2 diabetic rats under stress through the BDNF-TrkB signaling pathways" (2024), and "Targeted CYP2E1 quantification and its correlation to currently acceptable clinical biochemical indices" (2016). She has garnered awards such as Best Presentation at the 5th World Congress on Diabetes and Metabolism (2014, Las Vegas), Best Presentation at the 2nd World Congress on Clinical Trials in Diabetes (2017, Berlin), and First Prize at Monash CSJB Research Week (2017). Recent funding includes a Seed Grant Award (2024). Ongoing projects investigate renal protection by tocotrienol-rich vitamin E in type 2 diabetes rat models (2024–2027), anti-obesity effects of Karanjin (2023–2026), and neuroprotective effects of environmental enrichment in diabetic rats.